Naureen Quibria
Stock Analyst at Capital One
(0)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BMEA Biomea Fusion | Initiates Coverage On: Overweight | 25 | 1.86 | 1244.09% | 1 | Aug 29, 2024 | |
IMMP Immutep | Initiates Coverage On: Overweight | 10 | 1.65 | 506.06% | 1 | May 17, 2024 | |
ERAS Erasca | Initiates Coverage On: Overweight | 8 | 1.29 | 520.16% | 1 | Mar 11, 2024 | |
CARM CARISMA Therapeutics | Initiates Coverage On: Overweight | 10 | n/a | n/a | 1 | Oct 3, 2023 | |
IMCR Immunocore Hldgs | Initiates Coverage On: Overweight | 84 | 31.15 | 169.66% | 1 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 40 | 6.47 | 518.24% | 1 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 11 | 8.16 | 34.8% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 7 | n/a | n/a | 2 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 21 | 3.1 | 577.42% | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | n/a | n/a | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 900 | 6.17 | 14486.71% | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | n/a | n/a | 1 | Mar 16, 2021 |